Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Targeting PLK1 as NSCLC Therapeutics for Anticancer Therapy: Design and Synthesis of Selective Inhibitors
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 하정미 | - |
| dc.date.accessioned | 2024-12-14T21:31:34Z | - |
| dc.date.available | 2024-12-14T21:31:34Z | - |
| dc.date.issued | 2024-10-22 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/121293 | - |
| dc.title | Targeting PLK1 as NSCLC Therapeutics for Anticancer Therapy: Design and Synthesis of Selective Inhibitors | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 2024 대한 약학회 추계 학술대회 | - |
| dc.citation.conferencePlace | 더케이호텔, 서울 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - COLLEGE OF PHARMACY > DEPARTMENT OF PHARMACY > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Hah, Jung Mi
- COLLEGE OF PHARMACY (DEPARTMENT OF PHARMACY)